Genesis Biosciences European facility completes successful ISO 9001:2008 surveillance audit

The Genesis Biosciences European facility completed its first re-certification, having come to the end of the three year certification cycle, in May 2013. The re-certification was successful with no corrective actions. In July 2014 the first annual surveillance of the current three year certification cycle was carried out and, once again, no corrective actions were raised.

“Our recertification in 2013 with no corrective actions and the recent audit with no corrective actions shows that Genesis Biosciences continues to be committed to quality objectives” stated Debbie Williams, the European Operations Manager who is also responsible for company quality management standards globally.